Suppr超能文献

四齿铜螯合剂的制备作为潜在的抗阿尔茨海默病药物。

Preparation of Tetradentate Copper Chelators as Potential Anti-Alzheimer Agents.

机构信息

School of Chemical Engineering and Light Industry, Guangdong University of Technology (GDUT), no. 100 Waihuan Xi Road, Education Mega Center, Guangzhou, P.R. China.

Laboratoire de Chimie de Coordination du CNRS, Centre National de la Recherche Scientifique, 205 route de Narbonne, BP 44099, 31077, Toulouse cedex 4, France.

出版信息

ChemMedChem. 2018 Apr 6;13(7):684-704. doi: 10.1002/cmdc.201700734. Epub 2018 Feb 23.

Abstract

The uncontrolled redox activity of metal ions, especially copper, in the brains of patients with Alzheimer's disease (AD) should be considered the origin of intense oxidative damage to neurons in the AD brain. To obtain low-molecular-weight copper chelators that act as tetradentate ligands, we designed new compounds based on an 8-aminoquinoline motif with a lateral chain attached at the 2-position of the aromatic ring. Some of these new ligands, termed TDMQ for TetraDentate MonoQuinolines, are specific for copper chelation. Full characterization of these ligands is reported, as well as their affinities for Cu , and their capacities to inhibit oxidative stress induced by copper-amyloids activated by a reductant. Such metal ligands can be considered as potential anti-AD agents, as they should be able to regulate the homeostasis of copper in brain tissue.

摘要

金属离子(尤其是铜)在阿尔茨海默病(AD)患者大脑中的不受控制的氧化还原活性,应被视为 AD 大脑中神经元受到强烈氧化损伤的根源。为了获得作为四齿配体发挥作用的低分子量铜螯合剂,我们以带有侧链的 8-氨基喹啉基序为基础设计了新的化合物,该侧链连接在芳环的 2-位。这些新配体中的一些,被称为 TetraDentate MonoQuinolines(四齿单喹啉),是专门用于铜螯合的。报告了这些配体的全面特征,以及它们对 Cu 的亲和力和它们抑制由还原剂激活的铜-淀粉样蛋白诱导的氧化应激的能力。这些金属配体可以被认为是有潜力的抗 AD 药物,因为它们应该能够调节脑组织中铜的动态平衡。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验